Published: May, 2018
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players in the U.S. market are emphasizing on collaborations and mergers and acquisitions in order to broaden their product portfolio. In addition, they are also focusing on development of new product in order to maintain their leading position in the coming years. Some of the key players operating in the U.S. uterine fibroids treatment market are Smith & Nephew, Boston Scientific Corporation, and Hologic, Inc.
As per the report published by Transparency Market Research, in 2015, the U.S. market for uterine fibroids treatment was worth US$211.6 mn. The market is estimated to reach a value of US$273.6 mn by the end of 2024, exhibiting a healthy 2.90% CAGR between 2016 and 2024.
Hospital Segment to Account for High Share in U.S. Uterine Fibroids Treatment Market
On the basis of end user, the U.S. market for uterine fibroids treatment has been categorized into ambulatory surgical centers and hospitals. As per the study, the hospitals segment is likely to observe a high growth over the forecast period. The high growth of this segment can be attributed to the fact that hospitals are highly developed and are capable to handle complicated emergency situations and matters related to uterine fibroids. The increasing demand for hospitals and the rising focus on training interventional gynecologists and radiologists for the application of robotic minimally invasive procedure and radio frequency ablation are some of the major factors that are estimated to accelerate the growth of this segment in the next few years. Furthermore, the ambulatory surgical centers is estimated to grow at a sluggish pace throughout the forecast period.
In terms of type of procedure, the hysterectomy segment is projected to account for a large share of the U.S. market throughout the forecast period. This procedure is being recommended highly by doctors to women, who have a large size fibroid and have completed their fertility. On the other hand, in the next few years, there might be a downfall in the demand for hysterectomy treatment, due to the injury to healthy tissues and the increasing risks of having benign neoplasms after the procedure of hysterectomy.
Demand for Minimally Invasive Surgeries to Encourage Market Growth
The rising demand for minimally invasive surgeries for treating the excruciating painful uterine fibroids is one of the major factors anticipated to encourage the growth of the market throughout the forecast period. Reduced chances of infections, minimal recovery time, and shorter hospital stays are some of the major advantages of the treatment, thanks to which the market is likely to witness significant growth in the next few years. Technological advancements and the increasing research and development activities are projected to accelerate the overall growth of the market throughout the forecast period.
This information is based on the findings of a research report published by Transparency Market Research (TMR), titled “Uterine Fibroids Treatment Market (Procedure Type – Endometrial Ablation, MRI Guided Procedures (Percutaneous Laser Ablation and Transcutaneous Focused Ultrasound), Hysterectomy (Abdominal, Vaginal, Laparoscopic, Robotic, and Hysteroscopic Morcellation), Myomectomy (Open, Laparoscopic, and Robotic), Uterine Artery Embolization, and Radiofrequency Ablation; End User – Hospitals and Ambulatory Surgical Centers – U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”
- The rising demand for minimally invasive surgeries is expected to encourage the growth of the U.S. uterine fibroids treatment market in the next few years.
- Increasing research and development activities and launch of new products to generate promising growth opportunities for market players.
The U.S. Uterine Fibroid Treatment market has been segmented as below:
U.S. Uterine Fibroid Treatment Market, by Procedure
- Procedure Type
- Endometrial Ablation
- MRI Guided Procedures
- Uterine Artery Embolization
- Radiofrequency Ablation
- Procedure Sub Type
- MRI Guided Procedures
- MRI-guided Percutaneous Laser Ablation
- MRI Guided Transcutaneous Focused Ultrasound
- Abdominal Hysterectomy
- Vaginal Hysterectomy
- Laparoscopic Hysterectomy
- Robotic Hysterectomy
- Hysteroscopic Morcellation
- Open Myomectomy
- Laparoscopic Myomectomy
- Robotic Myomectomy
- MRI Guided Procedures
U.S. Uterine Fibroid Treatment Market, by End User
- Ambulatory Surgical Centers
U.S. Uterine Fibroid Treatment Market, by Geography
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact